BLICKENSTAFF KIM D 4
4 · TANDEM DIABETES CARE INC · Filed May 24, 2024
Insider Transaction Report
Form 4
BLICKENSTAFF KIM D
DirectorPRESIDENT AND CEO
Transactions
- Exercise/Conversion
Common Stock
2024-05-24$51.73/sh+4,434$229,371→ 17,848 total - Exercise/Conversion
Restricted Stock Unit
2024-05-24−4,434→ 0 total→ Common Stock (4,434 underlying) - Award
Restricted Stock Unit
2024-05-23+4,387→ 4,387 total→ Common Stock (4,387 underlying)
Holdings
- 205,190(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
- [F2]Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
- [F3]Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F4]RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
- [F5]Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).